drugset / Trial / NCT06015243
The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, single-arm, multicenter, extension study to evaluate the long-term safety and efficacy of GR1802 injection in patients with Chronic Rhinosinusitis With Nasal Polyps
Timeline
- Start
- 2023-08-18
- Primary completion
- 2024-12-30
- Completion
- 2025-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GR1802 | Monoclonal antibody | 300 mg | Subcutaneous |